Innovating Works

QUAL

A stranger
NEUROFGL: Development of a novel FGL therapy and translational tests for regenerative treatment of neurologica... Qualissima participó en un FP7: Neurodegenerative disorders such as, Alzheimer’s disease (AD), Mild Cognitive Impairment (MCI), stroke, Traumatic Brain Injury (TBI) and chr...
financed
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.